We're nearly there, confident next year will see a changing of the guard. We need to finish this year off strongly with trial results and distribution agreements and cement in some partners next year for cellgro in the striate range and the nerve range. Then i reckon around February next year we will have a good idea on where ati is going to proceed. I will be extremely disappointed if We're not mid 70c range by years end and pushing $2 by mid next year.
OCC chart, page-1884
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3807 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 3666 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |